A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis
Background & Aims Silymarin is a complex mixture of 6 major flavonolignans and other minor polyphenolic compounds derived from the milk thistle plant Silybum marianum; it has shown antioxidant, anti-inflammatory and antifibrotic effects, and may be useful in patients with nonalcoholic fatty live...
Main Authors: | Chan, Wah Kheong, Nik Mustapha, Nik Raihan, Mahadeva, Sanjiv |
---|---|
Format: | Article |
Published: |
Elsevier
2017
|
Subjects: |
Similar Items
-
Limited applicability of cathepsin D for the diagnosis and monitoring of non‐alcoholic steatohepatitis
by: Kamarajah, Sivesh Kathir, et al.
Published: (2019) -
Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease
by: Kamarajah, Sivesh Kathir, et al.
Published: (2018) -
Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
by: Chan, Wah Kheong, et al.
Published: (2018) -
Association between non‐alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community
by: Tan, Eugene Choon Li, et al.
Published: (2019) -
Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative
by: Chan, Wah Kheong, et al.
Published: (2018)